000766 通化金马
交易中 11-02 10:56:42
资讯
新帖
简况
股市必读：通化金马新发布《2026年三季度报告》
证券之星 · 10-28
股市必读：通化金马新发布《2026年三季度报告》
股市必读：通化金马三季报 - 第三季度单季净利润同比下降162.90%
证券之星 · 10-27
股市必读：通化金马三季报 - 第三季度单季净利润同比下降162.90%
通化金马(000766.SZ)发布前三季度业绩，归母净利润197.22万元，同比下降92.1%
智通财经 · 10-26
通化金马(000766.SZ)发布前三季度业绩，归母净利润197.22万元，同比下降92.1%
通化金马：公司新药琥珀酸安维吖啶片已启动商业化生产和销售工作
证券之星 · 10-16
通化金马：公司新药琥珀酸安维吖啶片已启动商业化生产和销售工作
通化金马（000766）10月14日主力资金净买入206.09万元
证券之星 · 10-15
通化金马（000766）10月14日主力资金净买入206.09万元
股市必读：通化金马（000766）10月14日董秘有最新回复
证券之星 · 10-15
股市必读：通化金马（000766）10月14日董秘有最新回复
通化金马：公司持续优化融资结构，管控融资成本
证券之星 · 10-14
通化金马：公司持续优化融资结构，管控融资成本
通化金马（000766）10月9日主力资金净卖出1511.30万元
证券之星 · 10-12
通化金马（000766）10月9日主力资金净卖出1511.30万元
通化金马（000766）10月8日主力资金净卖出1276.25万元
证券之星 · 10-09
通化金马（000766）10月8日主力资金净卖出1276.25万元
通化金马：公司坚持创新转型战略
证券之星 · 09-30
通化金马：公司坚持创新转型战略
公司问答丨通化金马：新药琥珀酸安维吖啶片用于轻、中度阿尔茨海默病症状的治疗
格隆汇 · 09-23
公司问答丨通化金马：新药琥珀酸安维吖啶片用于轻、中度阿尔茨海默病症状的治疗
通化金马：公司琥珀酸安维吖啶片已正式开展创新药首发价格挂网工作
证券之星 · 09-11
通化金马：公司琥珀酸安维吖啶片已正式开展创新药首发价格挂网工作
通化金马：公司正按计划推进新药商业化相关各项工作
证券之星 · 09-09
通化金马：公司正按计划推进新药商业化相关各项工作
通化金马：琥珀酸安维吖啶片正在开展商业化生产
证券之星 · 09-09
通化金马：琥珀酸安维吖啶片正在开展商业化生产
股市必读：通化金马（000766）9月8日董秘有最新回复
证券之星 · 09-09
股市必读：通化金马（000766）9月8日董秘有最新回复
通化金马：琥珀酸安维吖啶片注册分类为化学药品1类
证券之星 · 08-26
通化金马：琥珀酸安维吖啶片注册分类为化学药品1类
通化金马：公司已针对新药建立独立的销售布局
证券之星 · 08-26
通化金马：公司已针对新药建立独立的销售布局
股市必读：通化金马新发布《2026年半年度报告摘要》
证券之星 · 08-24
股市必读：通化金马新发布《2026年半年度报告摘要》
股市必读：通化金马中报 - 第二季度单季净利润同比下降138.78%
证券之星 · 08-21
股市必读：通化金马中报 - 第二季度单季净利润同比下降138.78%
通化金马（000766）披露2026年半年度报告及其摘要，8月20日股价上涨4.92%
证券之星 · 08-20
通化金马（000766）披露2026年半年度报告及其摘要，8月20日股价上涨4.92%
加载更多
公司概况
公司名称：
通化金马药业集团股份有限公司
所属行业：
医药制造业
上市日期：
1997-04-30
主营业务：
通化金马药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是琥珀酸安维吖啶片、复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾颗粒、芩石利咽口服液、乳酸亚铁口服液。公司获得了高新技术企业，荣获“中华民族医药百强品牌企业”、2015年度最具资本力企业奖、2017创新中国十大发展潜力企业、“2022-2023年度中国医药制造业百强”、2023年度中国化药企业TOP100等称号。
发行价格：
7.23
{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"通化金马","latestPrice":13.71,"timestamp":1793588202000,"preClose":13.79,"halted":0,"volume":6719485,"delay":0,"changeRate":-0.0058,"floatShares":966000000,"shares":966000000,"eps":0.0117,"marketStatus":"交易中","change":-0.08,"latestTime":"11-02 10:56:42","open":13.83,"high":13.9,"low":13.52,"amount":91903200,"amplitude":0.0276,"askPrice":13.72,"askSize":1,"bidPrice":13.7,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.0117,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1793590200000},"marketStatusCode":2,"adr":0,"adjPreClose":13.79,"symbolType":"stock","openAndCloseTimeList":[[1793583000000,1793590200000],[1793595600000,1793602800000]],"highLimit":15.17,"lowLimit":12.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"isCdr":false,"pbRate":5.76,"roa":"--","peRate":1171.794872,"roe":"0.09%","epsLYR":0.04,"committee":-0.58002,"marketValue":13251000000,"turnoverRate":0.007,"status":1,"floatMarketCap":13239000000},"requestUrl":"/m/hq/s/000766","defaultTab":"news","newsList":[{"id":"2678248306","title":"股市必读：通化金马新发布《2026年三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678248306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678248306?lang=zh_cn&edition=full","pubTime":"2026-10-28 04:10","pubTimestamp":1793131854,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘，通化金马报收于14.57元，下跌3.12%，换手率1.3%，成交量12.56万手，成交额1.85亿元。公司公告汇总：通化金马2026年第三季度净利润为-513.24万元，同比下降162.90%；年初至报告期末净利润197.22万元，同比下降92.10%。年初至报告期末营业收入736,581,907.41元，同比下降17.45%；归属于上市公司股东的净利润1,972,188.97元，同比下降92.10%。基本每股收益0.0020元，同比下降92.25%。总资产4,624,592,408.61元，较上年度末增长3.30%；归属于上市公司股东的所有者权益2,312,502,661.68元，较上年度末增长0.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800005637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000766","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678113020","title":"股市必读：通化金马三季报 - 第三季度单季净利润同比下降162.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678113020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678113020?lang=zh_cn&edition=full","pubTime":"2026-10-27 02:55","pubTimestamp":1793040946,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年三季度报告2026年第三季度营业收入179,419,450.59元，同比下降25.94%；归属于上市公司股东的净利润-5,132,442.12元，同比下降162.90%。年初至报告期末营业收入736,581,907.41元，同比下降17.45%；归属于上市公司股东的净利润1,972,188.97元，同比下降92.10%。经营活动产生的现金流量净额55,849,992.48元，同比下降21.13%。基本每股收益0.0020元，同比下降92.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678681551","title":"通化金马(000766.SZ)发布前三季度业绩，归母净利润197.22万元，同比下降92.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678681551","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678681551?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:24","pubTimestamp":1793003070,"startTime":"0","endTime":"0","summary":"智通财经APP讯，通化金马(000766.SZ)发布2026年第三季度报告，公司前三季度实现营业收入7.37亿元，同比下降17.45%;归属于上市公司股东的净利润197.22万元，同比下降92.10%;归属于上市公司股东的扣除非经常性损益的净亏损212.72万元;基本每股收益0.002元。公司业绩变动主要系本期销售收入下降所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675550713","title":"通化金马：公司新药琥珀酸安维吖啶片已启动商业化生产和销售工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2675550713","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675550713?lang=zh_cn&edition=full","pubTime":"2026-10-16 11:48","pubTimestamp":1792122489,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)10月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，咨询耄安通商业化问题：1. 目前耄安通已在黑龙江体系内医院实现供货，请问该供货属于院内临床试用，还是正式商业化销售？2. 如果本次医保谈判落地，新版目录执行后，公司是否会同步加快全国各省医院准入、药事进院工作？3. 当前除黑龙江体系医院外，还有哪些省份医院完成入院？谢谢。通化金马回复：您好，公司新药琥珀酸安维吖啶片已启动商业化生产和销售工作，正在推进琥珀酸安维吖啶片在各省首发价格挂网工作。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600017672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675376293","title":"通化金马（000766）10月14日主力资金净买入206.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675376293?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:07","pubTimestamp":1792026470,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，通化金马报收于14.59元，上涨1.39%，换手率1.27%，成交量12.27万手，成交额1.79亿元。10月14日的资金流向数据方面，主力资金净流入206.09万元，占总成交额1.15%，游资资金净流出520.15万元，占总成交额2.91%，散户资金净流入314.05万元，占总成交额1.76%。近5日资金流向一览见下表：通化金马融资融券信息显示，融资方面，当日融资买入977.58万元，融资偿还635.28万元，融资净买入342.3万元。通化金马主营业务：医药产品的研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500008058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675798321","title":"股市必读：通化金马（000766）10月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675798321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675798321?lang=zh_cn&edition=full","pubTime":"2026-10-15 02:44","pubTimestamp":1792003450,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，通化金马报收于14.59元，上涨1.39%，换手率1.27%，成交量12.27万手，成交额1.79亿元。董秘最新回复投资者： 公司有关注光遗传学领域吗董秘： 您好，公司密切关注行业前沿技术的发展动态，根据市场需求，结合自身情况，审慎论证。当日关注点交易信息汇总：10月14日主力资金净流入206.09万元，占总成交额1.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","000766","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675934258","title":"通化金马：公司持续优化融资结构，管控融资成本","url":"https://stock-news.laohu8.com/highlight/detail?id=2675934258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675934258?lang=zh_cn&edition=full","pubTime":"2026-10-14 20:51","pubTimestamp":1791982268,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，2026半年报公司有息负债约20.22亿元，利息支出较高，息税前利润已难以覆盖利息。公司根据自身生产经营实际需求，合理开展银行贷款等融资业务，同时公司持续优化融资结构，管控融资成本。有关公司的重大信息，请投资者关注公司公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400037677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0077","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674610847","title":"通化金马（000766）10月9日主力资金净卖出1511.30万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674610847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674610847?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:09","pubTimestamp":1791767357,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，通化金马报收于14.97元，上涨4.25%，换手率1.66%，成交量16.06万手，成交额2.38亿元。10月9日的资金流向数据方面，主力资金净流出1511.3万元，占总成交额6.36%，游资资金净流出1753.24万元，占总成交额7.38%，散户资金净流入3264.54万元，占总成交额13.74%。近5日资金流向一览见下表：通化金马融资融券信息显示，融资方面，当日融资买入1049.33万元，融资偿还1144.92万元，融资净偿还95.6万元。通化金马主营业务：医药产品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200002944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674881294","title":"通化金马（000766）10月8日主力资金净卖出1276.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674881294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674881294?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:15","pubTimestamp":1791508558,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，通化金马报收于14.36元，下跌5.28%，换手率1.57%，成交量15.13万手，成交额2.24亿元。10月8日的资金流向数据方面，主力资金净流出1276.25万元，占总成交额5.71%，游资资金净流出52.39万元，占总成交额0.23%，散户资金净流入1328.65万元，占总成交额5.94%。近5日资金流向一览见下表：通化金马融资融券信息显示，融资方面，当日融资买入1583.3万元，融资偿还2292.55万元，融资净偿还709.25万元。通化金马主营业务：医药产品的研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0060","BK0239","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671279700","title":"通化金马：公司坚持创新转型战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2671279700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671279700?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:48","pubTimestamp":1790754488,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司二级市场流动性枯竭，公司是否关注通化金马回复：您好，公司坚持创新转型战略，不断提高自身竞争力，促进公司经营业绩的稳步提升。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000021118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","BK0239","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669103480","title":"公司问答丨通化金马：新药琥珀酸安维吖啶片用于轻、中度阿尔茨海默病症状的治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2669103480","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669103480?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:16","pubTimestamp":1790147796,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","000766","BK0077","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666484915","title":"通化金马：公司琥珀酸安维吖啶片已正式开展创新药首发价格挂网工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2666484915","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666484915?lang=zh_cn&edition=full","pubTime":"2026-09-11 11:51","pubTimestamp":1789098666,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：新药价格何时公布？通化金马回复：您好，公司琥珀酸安维吖啶片已正式开展创新药首发价格挂网工作，首发价格定价以各省价格平台公示数据为准。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100024958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK0239","BK0060","06978","BK0077","000766","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666715533","title":"通化金马：公司正按计划推进新药商业化相关各项工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2666715533","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666715533?lang=zh_cn&edition=full","pubTime":"2026-09-09 20:53","pubTimestamp":1788958388,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问：新药上市为何没人和营销宣传，药效好不用打广告？通化金马回复：您好，公司正按计划推进新药商业化相关各项工作，药品推广需遵守相关监管规定，后续进展请以公司公告为准，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900037341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553374","title":"通化金马：琥珀酸安维吖啶片正在开展商业化生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553374","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666553374?lang=zh_cn&edition=full","pubTime":"2026-09-09 20:53","pubTimestamp":1788958388,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问：什么时候能买到新药通化金马回复：您好，公司琥珀酸安维吖啶片正在开展商业化生产并且推进首发价格挂网工作，当前新药的销售渠道协调和发货工作正在有序推进。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900037340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0239","BK0060","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374130","title":"股市必读：通化金马（000766）9月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666374130?lang=zh_cn&edition=full","pubTime":"2026-09-09 00:51","pubTimestamp":1788886276,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，通化金马报收于17.17元，上涨2.39%，换手率1.63%，成交量15.78万手，成交额2.71亿元。董秘最新回复投资者： 吗利福肽什么时候可以完成二期临床董秘： 您好，有关本公司的重大信息，均会在指定信息披露媒体发布，请投资者关注公司公告。当日关注点交易信息汇总：9月8日主力资金净流入2757.92万元，占总成交额10.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900002015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0060","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662958047","title":"通化金马：琥珀酸安维吖啶片注册分类为化学药品1类","url":"https://stock-news.laohu8.com/highlight/detail?id=2662958047","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662958047?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:48","pubTimestamp":1787730494,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)08月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司新药属于BIC并不是FIC吧，不能算创新药，还是老思路，不能逆转病情。通化金马回复：您好，根据《药品注册证书》，琥珀酸安维吖啶片注册分类为化学药品1类。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600031605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","000766","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795803","title":"通化金马：公司已针对新药建立独立的销售布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662795803?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:48","pubTimestamp":1787730493,"startTime":"0","endTime":"0","summary":"证券之星消息，通化金马(000766)08月25日在投资者关系平台上答复投资者关心的问题。投资者提问：新药建立独立的销售布局效率低，成员有经验，还是有什么销售计划，核爆级的？通化金马回复：您好，公司已针对新药建立独立的销售布局。如有涉及公司应披露的重大事项，公司将会严格按照相关法律法规的规定履行信息披露义务，请投资者关注公司公告。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600031604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","BK0239","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661245381","title":"股市必读：通化金马新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661245381","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661245381?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:57","pubTimestamp":1787507829,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告摘要显示，营业收入同比下降14.28%，归母净利润同比下降57.72%；公司决定不派发现金红利、不送红股、不以公积金转增股本。公司公告汇总：截至2026年半年度末，上市公司与子公司等关联方非经营性资金往来余额合计295,479,924.60元，无控股股东及实际控制人非经营性资金占用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0060","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236034","title":"股市必读：通化金马中报 - 第二季度单季净利润同比下降138.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236034","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661236034?lang=zh_cn&edition=full","pubTime":"2026-08-21 00:58","pubTimestamp":1787245088,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润为-202.47万元，同比下降138.78%。公司公告汇总：公司因执行财政部《企业会计准则解释第19号》《第20号》，自2026年1月1日起变更会计政策，无需提交董事会或股东会审议。其中第二季度单季度主营收入2.57亿元，同比下降26.7%；单季度归母净利润-202.47万元，同比下降138.78%；单季度扣非净利润-227.19万元，同比下降152.09%；负债率50.75%，投资收益55.49万元，财务费用4194.75万元，毛利率75.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100000911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660400268","title":"通化金马（000766）披露2026年半年度报告及其摘要，8月20日股价上涨4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660400268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660400268?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:31","pubTimestamp":1787218317,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，通化金马报收于16.86元，较前一交易日上涨4.92%，最新总市值为162.95亿元。该股当日开盘16.38元，最高17.3元，最低16.04元，成交额达5.31亿元，换手率为3.28%。近日，通化金马药业集团股份有限公司召开第十二届董事会第二次会议，审议通过公司2026年半年度报告及其摘要。会议通知于2026年8月10日以微信、电子邮件形式发出，会议由董事长张玉富主持，9名董事全部出席。公司2026年半年度报告及其摘要同日披露于巨潮资讯网。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000031210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793588208071,"stockEarnings":[{"period":"1week","weight":-0.0849},{"period":"1month","weight":-0.0904},{"period":"3month","weight":-0.1864},{"period":"6month","weight":-0.441},{"period":"1year","weight":-0.4552},{"period":"ytd","weight":-0.4984}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41731人(较上一季度减少6.72%)","perCapita":"23138股","listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","registeredCapital":"96649万元","survey":" 通化金马药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是琥珀酸安维吖啶片、复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾颗粒、芩石利咽口服液、乳酸亚铁口服液。公司获得了高新技术企业，荣获“中华民族医药百强品牌企业”、2015年度最具资本力企业奖、2017创新中国十大发展潜力企业、“2022-2023年度中国医药制造业百强”、2023年度中国化药企业TOP100等称号。","listedPrice":7.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化金马,000766,通化金马股票,通化金马股票老虎,通化金马股票老虎国际,通化金马行情,通化金马股票行情,通化金马股价,通化金马股市,通化金马股票价格,通化金马股票交易,通化金马股票购买,通化金马股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}